Evidence map›Paper›PMID 24438170›Full record

SynthesisNutrition journal2014

Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials.

Nithya Neelakantan, Madanagopal Narayanan, Russell J de Souza, Rob M van Dam

2 registry-linked trialsAbstract readMeta-Analysis
In one paragraph

Synthesis in Nutrition journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02693392 nacompletedstarted 2016, after this paper: background citation

Clinical Evaluation of Fenugreek Seed Extract, a Nutraceutical in Patients With Type- 2 Diabetes: An Add-On Study

Ran2016Enrolled200Registered outcomes9Posted comparisons0ConditionsType-2 Diabetes MellitusArmsFenugreek Seed extract, Oral hypoglycemic agents (pre-specified) [Metformin, Sulfonylurea]
PMID 21654091PMID 17313713PMID 11868855other papers from this trial
Open the trial in the graph
NCT07038577 nacompletednot on this mapstarted 2025, after this paper: background citation

Impact of Fenugreek Supplementation on Obesity and Hyperglycemia Among Diabetic Adults in Saudi Arabia: A Quasi-Experimental Study

TypeinterventionalSponsorUniversity of HailRan2025 to 2025Enrolled80ConditionsType 2 Diabetes Mellitus (T2DM), Obesity and Type 2 Diabetes, HyperglycemiaArmsFenugreek Seed Powder
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. The Effect of Fenugreek (Health science reports · 2026
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. The Role of Fenugreek in the Management of Type 2 Diabetes.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nithya NeelakantanSaw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore. nidhineel@gmail.com.
Madanagopal Narayanan
Russell J de Souza
Rob M van Dam

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimFenugreek is a herb that is widely used in cooking and as a traditional medicine for diabetes in Asia. It has been shown to acutely lower postprandial glucose levels, but the long-term effect on glycemia remains uncertain. We systematically reviewed clinical trials of the effect of fenugreek intake on markers of glucose homeostasis.

methodsPubMed, SCOPUS, the Cochrane Trials Registry, Web of Science, and BIOSIS were searched up to 29 Nov 2013 for trials of at least 1 week duration comparing intake of fenugreek seeds with a control intervention. Data on change in fasting blood glucose, 2 hour postload glucose, and HbA1c were pooled using random-effects models.

resultsA total of 10 trials were identified. Fenugreek significantly changed fasting blood glucose by -0.96 mmol/l (95% CI: -1.52, -0.40; I² = 80%; 10 trials), 2 hour postload glucose by -2.19 mmol/l (95% CI: -3.19, -1.19; I² = 71%; 7 trials) and HbA1c by -0.85% (95% CI: -1.49%, -0.22%; I² = 0%; 3 trials) as compared with control interventions. The considerable heterogeneity in study results was partly explained by diabetes status and dose: significant effects on fasting and 2 hr glucose were only found for studies that administered medium or high doses of fenugreek in persons with diabetes. Most of the trials were of low methodological quality.

conclusionsResults from clinical trials support beneficial effects of fenugreek seeds on glycemic control in persons with diabetes. However, trials with higher methodology quality using a well characterized fenugreek preparation of sufficient dose are needed to provide more conclusive evidence.

Indexed as

Blood GlucoseDiabetes Mellitus, Type 2Glycated HemoglobinHomeostasisHumansHypoglycemic AgentsInsulinPhytotherapyPlant ExtractsTrigonellaBlood Glucosefenugreek seed mealGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinPlant Extracts

Identifiers

PMID24438170
PMCPMC3901758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.